Moody’s Says Peru’s President-Elect Keiko Fujimori Could Boost Investor Confidence 
Denmark Central Bank Intervenes to Support Krone Peg Against Euro 
South Korea Alleges Google Abused Android App Store Dominance, Eyes Major Fine 
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox 
Samsung to Invest $90 Billion in South Korea to Expand AI Chip, Display, and Battery Production 
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
Sodexo Raises 2026 Revenue Outlook After Strong Q3 Sales Beat 
Nike Q4 Earnings Beat Estimates as Wholesale Growth Offsets Direct Sales Weakness 
Brazil to Phase Out Gasoline Subsidy First as Diesel Support Stays Longer 
South Korean Stocks Tumble as AI Chip Selloff Hits Asian Markets 
ShareChat Eyes 2027 IPO After Reaching Operational Profitability, Report Says 
Gold Price Surges Above $4,120 as Weak US Jobs Data Lowers Fed Rate Hike Expectations 
Greece’s Bad Loan Crisis Continues to Limit Credit Access Despite Economic Recovery 
Goldman Sachs Says China Competition Weighs More on EU Growth Than Trade Deficit 
Trump Reports $1.4 Billion in Crypto Income as Digital Assets Become Top Wealth Source 
Wall Street Ends Mixed as Weak Jobs Data Lowers Fed Rate Hike Bets, Chip Stocks Tumble 
Lotte Biologics is reportedly accused of stealing the trade secrets of its rival, Samsung Biologics. A probe into the case was already launched by prosecutors, and officials will be especially checking into some of the company’s employees who were suspected of the crime.
According to The Korea Times, the Incheon District Prosecutors' Office dispatched investigators last week to search the headquarters of Lotte Biologics located in Seoul’s Lotte World Tower. The raid took place on Friday, Oct. 7, and during the search, authorities said they were able to secure the computers of three former workers who were revealed to have moved from Samsung Biologics to Lotte Biologics, but their job positions in the company were not revealed.
Prior to the investigation, it was reported that Samsung Biologics filed to apply for a court directive for the infringement of its company trade secrets in May. In the application for the injunction, it mentioned its three former employees who moved to Lotte Biologics in July.
While their job roles were not disclosed, the three people were said to have work duties related to Samsung Biologics’ core business. The trio was also said to have printed a large number of company documents before transferring to its rival firm, Lotte Biologics.
The Incheon District Court responded to the application by granting Lotte’s request and issuing an injunction against the infringement of trade secrets that were filed by Samsung’s biotechnology business unit on July 29. The directive was to prevent the leak of any business secrets that could be utilized by Lotte Biologics for its benefit.
"We cannot reveal the specifics of the investigation including the search and seizure," the prosecution body commented with regard to the recent raid at the Lotte Biologics HQ
Meanwhile, the biological CDMO (Contract Development Manufacturing Organization) division of the Lotte Group was said to have started hiring bio professionals in the last quarter of 2021 as it was preparing to jump into the bio business. Based on the reports, many of the new hires were recruited from Samsung Biologics.
